关于奇天


奇天基因分子诊断致力于打造人类健康美好明天

COMPANY PROFILE

Company Overview

2012 Year

The company was founded in August 2012.

3500 Ten thousand plus

Company registered capital

500 +

The company serves its customers.

Company

Jiangsu Qitian Gene Biotechnology Co., Ltd.

Founded in 2012, Qitian Gene specializes in the research and application of recombinase-aided isothermal nucleic acid amplification technology (commonly known as RAA technology), developing an innovative platform for rapid on-site molecular testing using RAA. The platform integrates sample-preparation techniques, nucleic acid detection technologies, and complementary instruments, offering a comprehensive molecular testing solution tailored to meet the demand for swift, on-the-spot analysis under all-weather field conditions. It effectively addresses critical challenges such as limited access to electricity and shortages of trained personnel in remote environments. As a specialized, niche, and innovative high-tech enterprise, Qitian Gene seamlessly combines raw material production, cutting-edge R&D, product design, and technology commercialization into one integrated operation.

After more than a decade of technological innovation and expertise accumulation, leveraging RAA technology, the company has successfully undertaken two major national projects: the "13th Five-Year Plan" National Key Project on Major Infectious Diseases and the Ministry of Science and Technology's flagship initiative, "Public Safety Risk Prevention, Control, and Emergency Technology Equipment." Both projects have already passed national acceptance tests and resulted in the development of two Class III medical device registration products and two Class I product filings—remarkable achievements that underscore the company's cutting-edge capabilities. In 2021, the company was selected to lead Wuxi City’s key technological research project aimed at tackling critical challenges in COVID-19 prevention and control. In 2023, it joined the National "14th Five-Year Plan" Key R&D Program focused on "Major Natural Disaster Prevention and Public Safety," while also taking charge of Wuxi City’s "Taihu Light" science and technology innovation project that same year. To support its advanced R&D and manufacturing capabilities, the company boasts state-of-the-art facilities, including a GMP-compliant production facility, an independent quality inspection laboratory, a dedicated R&D center, and an advanced instrument production line. Additionally, the company has achieved robust international certifications, including ISO13485 and ISO9001 for its quality management systems, and has earned prestigious accolades such as National High-Tech Enterprise status and Jiangsu Province’s recognition as a Specialized, Sophisticated, and Novel Small-to-Medium-Sized Enterprise.

3500 Ten thousand plus
Culture

Leading Player in On-Site Molecular Testing

Our vision is to become the leader in on-site molecular testing, driving industry advancement through exceptional R&D capabilities and innovative strength—while contributing to the protection of human life and safety.

Vision

Culture

Racing against time to safeguard lives and ensure safety.

Our mission is to dedicate ourselves to innovating and developing a biosafety control system that is "more accurate, faster, and more convenient," continuously advancing molecular detection technologies and driving product innovation. We aim to build a fully integrated industrial chain for biosafety products, fostering a more harmonious environment and ensuring safer, healthier lives for people worldwide.

Mission

Culture

Empowering customers, relentlessly driving innovation, embracing responsibility, and fostering win-win collaboration.

Qitian Gene's Corporate Values

Values

Development Journey

DEVELOPMENT HISTORY

2024年

Development

● 非洲猪瘟检测试剂盒获批三类新兽药 ● 钉螺一体化项目获得江苏省科学技术二等奖

2023年

Development

● 认定为江苏省专精特新企业 ● 承担无锡市“太湖之光”科技攻关项目 ● 参与国家“十四五”重点研发计划 ● 参与“重大自然灾害防控与公共安全”项目

2021年

Development

● 承担无锡市新冠肺炎疫情防控关键技术攻关揭榜项目 ● 荧光检测仪器、新冠检测试剂盒获得三类注册证

2020年

Development

● 与国家CDC联合研制新冠试剂盒获得CE认证 ● 三类医疗产品通过注册检验 ● 内源性内标多重靶标技术取得重大突破

2019年

Development

● 获得国家高新技术企业认证 ● 获得医疗器械生产许可ISO13485、ISO9001质量管理体系认证

2017年

Development

● 承担国家“十三五”重大传染病专项

2014年

Development

● RAA等温核酸扩增反应试剂及等温核酸扩增方法获得授权

Employee Highlights

STAFF STYLE

The employees of Jiangsu Qitian Gene Biotechnology Co., Ltd. shine brightly: blending vibrant team energy with unwavering professionalism, they are jointly setting a new benchmark in the field of molecular diagnostics.

Honorary Qualifications

HONORS AND QUALIFICATIONS

ISO9001
ISO13485
CE
Isothermal Nucleic Acid Amplification Reagents and Isothermal Nucleic Acid Amplification Method
RAP Gene Detection Kit, Detection Method and Applications, as well as RAP Virus Detection Kit
A rapid respiratory syncytial virus detection method with internal reference using dual isothermal nucleic acid amplification
A method for detecting Schistosoma DNA using fluorescent probes
An amplification system and method for detecting Japanese encephalitis virus RNA
A method for fluorescence quantitative analysis based on recombinase-mediated isothermal nucleic acid amplification (RAA).
Rapid Detection of Adenovirus Type 7 Using a Dual Isothermal Nucleic Acid Amplification Method with Internal Control
Rapid Detection of Human Adenovirus Type 3 with Internal-Reference Dual Isothermal Nucleic Acid Assay
恒温振荡 Mixer
Water sample filtration device for detecting two types of parasites in drinking water
Test tube caps and nucleic acid test tubes
恒温荧光检测仪器软件
Thermostable Nucleic Acid Amplification Analysis System Embedded Software V1.0
Thermal Cycling Nucleic Acid Amplification Analysis System PC Software V1.0
Category I Filing Certificate (Sample Pre-processing System)
COVID-19 Test Kit Registration Certificate (In Vitro Diagnostic Reagent)
Class III Registration Certificate (Constant-Temperature Nucleic Acid Amplification Analyzer)

News and Information

NEWS INFORMATION